98%
921
2 minutes
20
Background: The impact of past air quality improvements on health and equity at low pollution levels near the revised WHO air quality guidelines remains largely unknown. Less is known about the influence of simultaneous reductions in multiple major pollutants. Leveraging real-world improvements in air quality across Canada, we sought to directly evaluate their health benefits by quantifying the impact of a joint shift in three criteria pollutants on mortality in a national cohort.
Methods: In this population-based cohort study, we assembled a cohort of 2·7 million adults living in Canada in 2007 who were followed up through 2016. Annual mean concentrations of fine particulate matter (PM), nitrogen dioxide (NO), and ozone (O) were assigned to participants' residential locations. For each pollutant individually and combined, we conducted a causal analysis of the impact of the decadal shift in annual exposure from the pre-baseline level (2004-06) on the risk of non-accidental mortality using the parametric g-formula, a structural causal model. To check the robustness of our results, we conducted multiple sensitivity analyses, including exploring alternative exposure scenarios. We also evaluated differential benefits across regions and socio-demographic subgroups.
Findings: Between 2007 and 2016, annual mean exposures to PM and NO decreased (from 7·1 μg/m [SD 2·3] to 5·5 μg/m [1·9] for PM and from 11·1 ppb [SD 6·6] to 8·0 ppb [4·9] for NO), whereas O declined initially and then rebounded (from 38·6 [SD 8·3] ppb to 36·0 [6·0] ppb and then 38·1 [5·4] ppb). Compared to pre-baseline (2004-06) levels, the joint change in the pollution exposures beginning in 2007 resulted in, per million population, 70 (95% CI 29-111) fewer deaths by 2009, 416 (283-549) fewer deaths by 2012, and 609 (276-941) fewer deaths by 2016, corresponding to a -0·7% change in mortality risk over the decade. Stratified analyses showed greater beneficial impacts in men, adults aged 50 years and older, low income-earners, and residents in regions undergoing substantial air quality improvements. Had all regions experienced pollution reductions similar to the most improved region, approximately three times as many deaths would have been averted (2191 fewer deaths per million). Conversely, if the observed air quality improvements had been delayed in all regions by 3 years, there would have been 429 more deaths per million by 2016.
Interpretation: In Canada, substantial health gains were associated with air quality improvements at levels near the revised WHO guidelines between 2007 and 2016, with notable heterogeneity observed across socio-demographic subgroups and regions. These findings indicate that modest declines in air pollution can considerably improve health and equity, even in low-exposure environments.
Funding: Health Canada.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/S2542-5196(25)00002-6 | DOI Listing |
Ann Am Thorac Soc
September 2025
Brigham and Women's Hospital, Division of Sleep and Circadian Disorders, Boston, Massachusetts, United States.
Rationale: There are insufficient data to inform the management of central sleep apnea (CSA) in patients with heart failure (HF) with reduced ejection fraction (HFrEF). Nocturnal oxygen therapy (NOT) has been postulated to benefit CSA patients with HFrEF, but has not been rigorously studied. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.
View Article and Find Full Text PDFAm J Respir Crit Care Med
September 2025
Emory University, Atlanta, Georgia, United States;
Background: Wildfires significantly affect air quality in the Western United States. Although prior research has linked wildfire smoke PM to respiratory health outcomes, these studies typically have limited geographic and temporal coverage, lacking evidence from multiple states over extended periods.
Methods: We obtained data on over 6 million emergency department (ED) visits for respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), upper respiratory infections (URI), and bronchitis, from five states in the Western US during 2007-2018.
J Bras Pneumol
September 2025
. Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo (SP) Brasil.
Objective: To describe the sociodemographic and clinical characteristics of individuals exposed to smoking or biomass smoke and followed at primary health care (PHC) centers across three states in Brazil.
Methods: This was a cross-sectional multicenter study including patients followed at any of four PHC centers in Brazil. Patients ≥ 35 years of age who were smokers or former smokers, or were exposed to biomass smoke were included, the exception being those with physical/mental disabilities and those who were pregnant.
Int J Surg
September 2025
Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Background: Bladder cancer represents a significant global health challenge, characterized by poorly understood risk factors. This study aims to synthesize meta-analytical evidence, quantify risk associations, and inform prevention strategies.
Methods: We conducted a comprehensive literature search in PubMed, Embase, Web of Science, and Cochrane Library up to October 2024.
Infect Control Hosp Epidemiol
September 2025
Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Background: Admission to shared hospital rooms are a risk factor of healthcare-associated (HA) SARS-CoV-2. Quantifying the impact of engineering controls such as ventilation and filtration is essential to informing resource utilization and infection prevention guidelines.
Methods: Multicenter test-negative study of patients exposed to SARS-CoV-2 in shared rooms across five hospitals between January and October, 2022.